Personal tools

Coexpression cluster:C102

From FANTOM5_SSTAR

Revision as of 10:31, 17 September 2013 by Autoedit (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Full id: C102_neuroblastoma_testicular_pituitary_carcinosarcoma_rectum_acantholytic_iPS



Phase1 CAGE Peaks

Hg19::chr10:127350469..127350475,-p@chr10:127350469..127350475
-
Hg19::chr10:127350497..127350505,-p@chr10:127350497..127350505
-
Hg19::chr11:133821367..133821390,-p@chr11:133821367..133821390
-
Hg19::chr11:68450506..68450518,+p@chr11:68450506..68450518
+
Hg19::chr11:68451165..68451175,+p4@GAL
Hg19::chr11:68451232..68451268,+p5@GAL
Hg19::chr11:68452002..68452019,+p1@GAL
Hg19::chr11:71952309..71952319,-p2@PHOX2A
Hg19::chr11:71955016..71955024,-p7@PHOX2A
Hg19::chr12:122711996..122712008,-p5@DIABLO
Hg19::chr12:122712038..122712049,-p8@DIABLO
Hg19::chr12:49688923..49688936,+p1@PRPH
Hg19::chr14:104690772..104690782,+p@chr14:104690772..104690782
+
Hg19::chr14:104760121..104760131,+p@chr14:104760121..104760131
+
Hg19::chr14:104760198..104760243,+p@chr14:104760198..104760243
+
Hg19::chr14:104760559..104760564,+p@chr14:104760559..104760564
+
Hg19::chr14:104760576..104760581,+p@chr14:104760576..104760581
+
Hg19::chr14:104760588..104760595,+p@chr14:104760588..104760595
+
Hg19::chr14:104760605..104760614,+p@chr14:104760605..104760614
+
Hg19::chr15:74495513..74495544,-p8@STRA6
Hg19::chr16:57980377..57980387,-p@chr16:57980377..57980387
-
Hg19::chr16:57980404..57980415,-p@chr16:57980404..57980415
-
Hg19::chr16:57980416..57980425,-p@chr16:57980416..57980425
-
Hg19::chr16:57980435..57980443,-p@chr16:57980435..57980443
-
Hg19::chr16:57980444..57980463,-p@chr16:57980444..57980463
-
Hg19::chr17:42101631..42101637,-p@chr17:42101631..42101637
-
Hg19::chr17:74540218..74540227,+p12@PRCD
Hg19::chr17:74540293..74540300,+p15@PRCD
Hg19::chr19:4279647..4279659,+p9@SHD
Hg19::chr19:4279661..4279707,+p3@SHD
Hg19::chr19:48876376..48876383,+p@chr19:48876376..48876383
+
Hg19::chr19:48876384..48876391,+p@chr19:48876384..48876391
+
Hg19::chr19:48876418..48876427,+p@chr19:48876418..48876427
+
Hg19::chr19:48876547..48876593,+p@chr19:48876547..48876593
+
Hg19::chr19:48876664..48876672,+p@chr19:48876664..48876672
+
Hg19::chr19:48876673..48876694,+p@chr19:48876673..48876694
+
Hg19::chr19:48876699..48876707,+p@chr19:48876699..48876707
+
Hg19::chr19:48876709..48876718,+p@chr19:48876709..48876718
+
Hg19::chr1:151688655..151688667,-p14@CELF3
Hg19::chr1:151688674..151688683,-p22@CELF3
Hg19::chr1:156626643..156626652,+p14@BCAN
Hg19::chr1:205325698..205325721,-p5@KLHDC8A
Hg19::chr1:207915129..207915176,+p@chr1:207915129..207915176
+
Hg19::chr1:235813246..235813266,-p7@GNG4
Hg19::chr1:245751682..245751686,-p@chr1:245751682..245751686
-
Hg19::chr1:50569575..50569586,+p11@ELAVL4
Hg19::chr21:46690262..46690294,-p7@POFUT2
Hg19::chr22:48962342..48962367,-p@chr22:48962342..48962367
-
Hg19::chr2:16040301..16040302,-p@chr2:16040301..16040302
-
Hg19::chr2:16081362..16081379,-p4@MYCNOS
Hg19::chr2:20691929..20691932,-p@chr2:20691929..20691932
-
Hg19::chr2:20691964..20691969,-p@chr2:20691964..20691969
-
Hg19::chr2:27651478..27651507,+p1@NRBP1
Hg19::chr2:27651519..27651539,+p2@NRBP1
Hg19::chr2:27712583..27712688,-p1@IFT172
Hg19::chr2:27805866..27805879,+p2@ZNF512
Hg19::chr2:27805880..27805967,+p1@ZNF512
Hg19::chr2:27805971..27805981,+p3@ZNF512
Hg19::chr2:27851885..27851930,+p1@GPN1
Hg19::chr2:27884081..27884103,+p@chr2:27884081..27884103
+
Hg19::chr2:27886228..27886239,-p6@SUPT7L
Hg19::chr2:27886258..27886282,-p3@SUPT7L
Hg19::chr2:27886408..27886419,-p4@SUPT7L
Hg19::chr2:27886420..27886431,-p7@SUPT7L
Hg19::chr2:27886432..27886452,-p2@SUPT7L
Hg19::chr2:27886460..27886511,-p1@SUPT7L
Hg19::chr2:27886747..27886783,+p1@SLC4A1AP
Hg19::chr2:27938593..27938615,-p1@ENST00000379677
p1@uc002rll.1
Hg19::chr2:27994567..27994641,+p1@MRPL33
Hg19::chr2:28113583..28113684,+p1@BRE
Hg19::chr2:29439699..29439702,-p@chr2:29439699..29439702
-
Hg19::chr2:29439775..29439786,-p@chr2:29439775..29439786
-
Hg19::chr2:29439892..29439900,-p@chr2:29439892..29439900
-
Hg19::chr2:29439948..29439958,-p@chr2:29439948..29439958
-
Hg19::chr2:29439959..29439970,-p@chr2:29439959..29439970
-
Hg19::chr2:29440063..29440070,-p@chr2:29440063..29440070
-
Hg19::chr2:29440093..29440103,-p@chr2:29440093..29440103
-
Hg19::chr2:29440116..29440123,-p@chr2:29440116..29440123
-
Hg19::chr2:29440133..29440140,-p@chr2:29440133..29440140
-
Hg19::chr2:29440175..29440180,-p@chr2:29440175..29440180
-
Hg19::chr2:29440253..29440264,-p@chr2:29440253..29440264
-
Hg19::chr2:29440474..29440512,-p@chr2:29440474..29440512
-
Hg19::chr2:29450467..29450495,-p@chr2:29450467..29450495
-
Hg19::chr2:29484252..29484254,-p@chr2:29484252..29484254
-
Hg19::chr2:29519868..29519887,-p@chr2:29519868..29519887
-
Hg19::chr2:29576587..29576590,-p@chr2:29576587..29576590
-
Hg19::chr2:29626570..29626576,-p@chr2:29626570..29626576
-
Hg19::chr2:29645795..29645797,+p@chr2:29645795..29645797
+
Hg19::chr2:29650381..29650398,-p@chr2:29650381..29650398
-
Hg19::chr2:29653880..29653881,+p@chr2:29653880..29653881
+
Hg19::chr2:29655619..29655623,+p@chr2:29655619..29655623
+
Hg19::chr2:29658492..29658495,-p@chr2:29658492..29658495
-
Hg19::chr2:29703653..29703657,-p@chr2:29703653..29703657
-
Hg19::chr2:29706034..29706038,-p@chr2:29706034..29706038
-
Hg19::chr2:29727599..29727607,-p@chr2:29727599..29727607
-
Hg19::chr2:29728669..29728672,-p@chr2:29728669..29728672
-
Hg19::chr2:29731597..29731601,-p@chr2:29731597..29731601
-
Hg19::chr2:29747873..29747882,-p@chr2:29747873..29747882
-
Hg19::chr2:29747891..29747899,-p@chr2:29747891..29747899
-
Hg19::chr2:29747901..29747910,-p@chr2:29747901..29747910
-
Hg19::chr2:29747945..29747955,-p@chr2:29747945..29747955
-
Hg19::chr2:29747987..29747993,-p@chr2:29747987..29747993
-
Hg19::chr2:29748214..29748225,-p@chr2:29748214..29748225
-
Hg19::chr2:29796921..29796922,-p@chr2:29796921..29796922
-
Hg19::chr2:29822049..29822052,-p@chr2:29822049..29822052
-
Hg19::chr2:29836771..29836815,-p@chr2:29836771..29836815
-
Hg19::chr2:29863817..29863820,-p@chr2:29863817..29863820
-
Hg19::chr2:29891260..29891294,-p@chr2:29891260..29891294
-
Hg19::chr2:29892736..29892737,-p@chr2:29892736..29892737
-
Hg19::chr2:29894070..29894081,-p@chr2:29894070..29894081
-
Hg19::chr2:29894082..29894092,-p@chr2:29894082..29894092
-
Hg19::chr2:29902123..29902129,-p@chr2:29902123..29902129
-
Hg19::chr2:29902520..29902529,-p@chr2:29902520..29902529
-
Hg19::chr2:29902609..29902616,-p@chr2:29902609..29902616
-
Hg19::chr2:30106068..30106073,-p@chr2:30106068..30106073
-
Hg19::chr2:30106093..30106097,-p@chr2:30106093..30106097
-
Hg19::chr2:30106158..30106162,-p@chr2:30106158..30106162
-
Hg19::chr2:30128567..30128583,-p@chr2:30128567..30128583
-
Hg19::chr2:30130900..30130921,-p@chr2:30130900..30130921
-
Hg19::chr2:30132841..30132846,-p@chr2:30132841..30132846
-
Hg19::chr2:30133779..30133783,-p@chr2:30133779..30133783
-
Hg19::chr2:30142997..30143009,-p@chr2:30142997..30143009
-
Hg19::chr2:30143103..30143109,-p22@ALK
Hg19::chr2:30143599..30143606,-p15@ALK
Hg19::chr2:30143685..30143694,-p11@ALK
Hg19::chr2:30143749..30143756,-p16@ALK
Hg19::chr2:30143760..30143777,-p5@ALK
Hg19::chr2:30143805..30143814,-p6@ALK
Hg19::chr2:30143819..30143830,-p8@ALK
Hg19::chr2:30143841..30143861,-p4@ALK
Hg19::chr2:30144040..30144047,-p19@ALK
Hg19::chr2:30144102..30144111,-p9@ALK
Hg19::chr2:30144125..30144135,-p12@ALK
Hg19::chr2:30144214..30144224,-p14@ALK
Hg19::chr2:30144229..30144240,-p10@ALK
Hg19::chr2:30144445..30144457,-p1@ALK
Hg19::chr2:30144471..30144482,-p2@ALK
Hg19::chr2:30670077..30670125,+p1@LCLAT1
Hg19::chr2:30670127..30670186,+p2@LCLAT1
Hg19::chr2:30670193..30670200,+p5@LCLAT1
Hg19::chr2:30670209..30670220,+p4@LCLAT1
Hg19::chr2:30762138..30762142,+p@chr2:30762138..30762142
+
Hg19::chr2:30863199..30863211,+p@chr2:30863199..30863211
+
Hg19::chr2:30863696..30863716,+p@chr2:30863696..30863716
+
Hg19::chr2:30864128..30864141,+p8@LCLAT1
Hg19::chr2:30864391..30864426,+p6@LCLAT1
Hg19::chr2:30864461..30864472,+p11@LCLAT1
Hg19::chr2:30864778..30864794,+p@chr2:30864778..30864794
+
Hg19::chr2:30864827..30864835,+p@chr2:30864827..30864835
+
Hg19::chr2:30864920..30864931,+p@chr2:30864920..30864931
+
Hg19::chr2:30865194..30865203,+p9@LCLAT1
Hg19::chr2:30865283..30865293,+p3@LCLAT1
Hg19::chr2:30865408..30865436,+p7@LCLAT1
Hg19::chr3:132975822..132975848,-p@chr3:132975822..132975848
-
Hg19::chr3:132975886..132975894,-p1@ENST00000504993
Hg19::chr3:28617116..28617136,+p@chr3:28617116..28617136
+
Hg19::chr3:33998836..33998839,+p@chr3:33998836..33998839
+
Hg19::chr3:97448267..97448299,-p@chr3:97448267..97448299
-
Hg19::chr3:97455832..97455841,-p@chr3:97455832..97455841
-
Hg19::chr3:97483572..97483644,+p1@ARL6
Hg19::chr3:97483652..97483663,+p4@ARL6
Hg19::chr3:97483675..97483686,+p5@ARL6
Hg19::chr4:10057464..10057469,+p@chr4:10057464..10057469
+
Hg19::chr4:175204955..175204970,+p9@CEP44
Hg19::chr4:42400017..42400037,+p4@SHISA3
Hg19::chr4:48485147..48485178,+p6@SLC10A4
Hg19::chr5:16180622..16180633,-p@chr5:16180622..16180633
-
Hg19::chr5:16180836..16180838,-p6@MARCH11
Hg19::chr5:16180906..16180918,-p3@MARCH11
Hg19::chr5:16180927..16180934,-p7@MARCH11
Hg19::chr5:168272120..168272136,-p12@SLIT3
Hg19::chr5:168310338..168310348,-p@chr5:168310338..168310348
-
Hg19::chr5:168310353..168310356,-p@chr5:168310353..168310356
-
Hg19::chr5:168310490..168310493,-p@chr5:168310490..168310493
-
Hg19::chr5:168310509..168310521,-p@chr5:168310509..168310521
-
Hg19::chr5:168310523..168310542,-p@chr5:168310523..168310542
-
Hg19::chr6:119524135..119524144,+p@chr6:119524135..119524144
+
Hg19::chr6:119524165..119524187,+p@chr6:119524165..119524187
+
Hg19::chr6:123318989..123318999,+p@chr6:123318989..123318999
+
Hg19::chr6:159190463..159190467,-p@chr6:159190463..159190467
-
Hg19::chr6:44238930..44238942,+p4@TMEM151B
Hg19::chr6:44355325..44355340,+p4@CDC5L
Hg19::chr6:44355992..44356000,+p@chr6:44355992..44356000
+
Hg19::chr6:44356761..44356774,+p@chr6:44356761..44356774
+
Hg19::chr9:94955376..94955381,+p@chr9:94955376..94955381
+
Hg19::chr9:97372339..97372361,-p@chr9:97372339..97372361
-
Hg19::chrX:133847905..133847915,-p@chrX:133847905..133847915
-
Hg19::chrX:133847967..133848002,-p@chrX:133847967..133848002
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen
migratory neural crest cell1.77e-1041
neurectodermal cell9.44e-0859
Uber Anatomy
Ontology termp-valuen
sympathetic nervous system3.49e-795
autonomic nervous system3.49e-795
peripheral nervous system9.75e-458
Disease
Ontology termp-valuen
neuroendocrine tumor2.83e-666
neuroectodermal tumor2.00e-4010
germ cell and embryonal cancer3.41e-1922
germ cell cancer3.41e-1922


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.10.00204315
MA0004.10.101704
MA0006.10.429173
MA0007.10.20467
MA0009.10.235676
MA0014.19.76776e-05
MA0017.10.321344
MA0019.10.438045
MA0024.10.259113
MA0025.10.0521117
MA0027.11.17532
MA0028.11.34809
MA0029.10.0521295
MA0030.10.467851
MA0031.10.179359
MA0038.10.62341
MA0040.10.148031
MA0041.10.206246
MA0042.10.0844599
MA0043.10.236067
MA0046.10.0885381
MA0048.10.630295
MA0050.10.220061
MA0051.10.0542051
MA0052.10.0561965
MA0055.10.294162
MA0056.10
MA0057.10.0257468
MA0058.10.0665058
MA0059.10.0190658
MA0060.10.000899143
MA0061.10.00205411
MA0063.10
MA0066.10.30783
MA0067.10.777313
MA0068.13.12775
MA0069.10.0863589
MA0070.10.967929
MA0071.10.826299
MA0072.10.199545
MA0073.131.3155
MA0074.10.293737
MA0076.11.01397
MA0077.10.372845
MA0078.10.839285
MA0081.10.161888
MA0083.10.0993893
MA0084.10.22645
MA0087.10.19678
MA0088.10.370116
MA0089.10
MA0090.10.109752
MA0091.10.260514
MA0092.10.476684
MA0093.10.0870289
MA0095.10
MA0098.10
MA0100.11.42915
MA0101.10.198296
MA0103.10.103798
MA0105.10.00307513
MA0106.10.0913046
MA0107.10.0251477
MA0108.20.31961
MA0109.10
MA0111.10.293008
MA0113.10.672891
MA0114.10.22565
MA0115.10.0893407
MA0116.10.924542
MA0117.10.0286058
MA0119.11.74363
MA0122.10.136997
MA0124.10.256241
MA0125.10.400469
MA0130.10
MA0131.10.177189
MA0132.10
MA0133.10
MA0135.10.113906
MA0136.10.121243
MA0139.10.577272
MA0140.10.0689712
MA0141.10.855462
MA0142.10.265259
MA0143.10.197011
MA0144.10.369556
MA0145.10.175107
MA0146.10.00180828
MA0147.10.0180025
MA0148.11.49505
MA0149.10.966532
MA0062.20.194778
MA0035.20.0324658
MA0039.20.214056
MA0138.20.268763
MA0002.20.578479
MA0137.20.182314
MA0104.20.00379738
MA0047.21.25472
MA0112.20.0634616
MA0065.20.335616
MA0150.10.0158219
MA0151.10
MA0152.10.336411
MA0153.10.0425567
MA0154.11.26232
MA0155.10.0440614
MA0156.10.263219
MA0157.10.113395
MA0158.10
MA0159.10.69082
MA0160.10.0981307
MA0161.10
MA0162.10.00769181
MA0163.10.194672
MA0164.10.121645
MA0080.20.131113
MA0018.20.0152267
MA0099.20.0753029
MA0079.20.00089759
MA0102.20.250362
MA0258.10.0440901
MA0259.10.00315782
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
FAM48A#55578530.72257313829797.45128886397291e-073.29887731099816e-05
GATA2#2624342.304934462451254.14202266864013e-060.000131445975536344
POU5F1#546058.921255357763450.0002739619540582970.00292141234632372
REST#5978351.796547899279150.0004627111215062470.0042622232156457
WRNIP1#5689763.504892479235410.007894123635689410.0324065240512467
ZZZ3#2600956.367372671149820.001242005297878770.00835246563458857



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C102&oldid=3067220"